How do I implement an outpatient program for the administration of convalescent plasma for COVID‐19? is a research paper published in Transfusion (2022). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Center for Advancing Translational Sciences
Grant: U24TR001609‐S3
National Heart, Lung, and Blood Institute
Grant: 1K23HL151826
National Institute of Allergy and Infectious Diseases
Grant: 3R01AI152078‐01S1
U.S. Department of Defense
Grant: W911QY2090012
NIAID NIH HHS
Grant: R01 AI152078
NIAID NIH HHS
Grant: 3R01AI152078-01S1
Conjugate vaccines for prevention and treatment of cryptococcosis - COVID-19 Revision Supplement
NHLBI NIH HHS
Grant: K23 HL151826
NCATS NIH HHS
Grant: U24 TR001609
NCATS NIH HHS
Grant: U24TR001609-S3
NCATS NIH HHS
Grant: UL1 TR001409
NCATS NIH HHS
Grant: UL1 TR001414
National Institutes of Health
Grant: 5R01AI152078-04
Conjugate vaccines for prevention and treatment of cryptococcosis
National Institutes of Health
Grant: 5U24TR001609-06
Johns Hopkins-Tufts Trial Innovation Center
National Institutes of Health
Grant: 1K23HL151826-01
The Malaria Transfusion Risk (MATRix) Study
State of Maryland
Bloomberg Philanthropies
Intramural NIH HHS
Shear Family Foundation
Octapharma
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Intramural NIH HHS
FWCI
1.93
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals